Home / Guides / Switching from Zepbound
From Zepbound to compounded, carefully.
Switching from Zepbound to compounded tirzepatide: your dose, your units, your cost
By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD · Updated
Switching from Zepbound to compounded tirzepatide takes a licensed provider’s prescription; self-pay Zepbound costs $299 to $699 per 28 days, by dose and refill timing (checked November 1, 2026). Bring your dose in milligrams, not units. At NexLife, compounded tirzepatide is $139 a month on the 12-month plan, or $169 month to month, at every dose.
$139/mo on 12 months, every dosePrice Match Guarantee†
- Every Zepbound dose: 0.5 mL or 0.6 mL, at any strength
- Units don’t carry over: each compounded vial has its own strength
- NexLife: $139 a month on 12 months, at every dose
$139/mo on a 12-month plan, all-inclusive, same price at every dose
Or $169/mo month to month
On Zepbound now? A licensed provider reviews your current dose first
About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication
See all 4 plans and what a year costs
| Plan | Per month | 12 months at this rate |
|---|---|---|
| 12-month Lowest monthly price | $139 | $1,668 |
| 6-month | $149 | $1,788 |
| 3-month | $159 | $1,908 |
| Month to month | $169 | $2,028 |
Month to month costs $360 more over 12 months than the 12-month plan. Plans renew until you cancel. Longer plans bill the way you choose at checkout.
Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works
4.8 out of 5 on Trustpilot, 407 reviewsLegitScript-certified
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.
- Licensed U.S. providers
- LegitScript certified
- Free expedited shipping
- HSA, FSA, Affirm, Klarna, Afterpay
- 24/7 support, real people
- Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)
At a glance
Zepbound to compounded tirzepatide: dose, units, timing and cost
The short answers, from the sections below. Prices checked November 1, 2026.
| Question | Answer |
|---|---|
| Can you switch? | Yes, if a licensed provider decides compounded tirzepatide is right for you. It isn’t FDA-approved; Zepbound is. |
| What dose do you start on? | The one your provider prescribes, after reviewing your current dose and when you last took it. Not 2.5 mg by default. |
| Do your units carry over? | No. Every Zepbound dose is 0.5 mL or 0.6 mL, whatever the strength. A compounded vial’s units depend on its strength: for example, 5 mg is 50 units at 10 mg/mL, but 25 units at 20 mg/mL. |
| When is your first dose? | Usually on your next weekly Zepbound day, as your provider directs. One weekly dose, from one product. |
| What does Zepbound cost? | Self-pay, per 28 days: $299 at 2.5 mg and $399 at 5 mg. From 7.5 mg up, $449 with a refill within 45 days; without one, $499 at 7.5 mg and $699 at 10 to 15 mg (checked November 1, 2026). |
| What does NexLife charge? | $139 a month on the 12-month plan, or $169 month to month, at every dose: compounded tirzepatide, all in. |
- Tell us about you About 3 minutes of health questions
- A licensed provider decides You’re prescribed only if it’s right for you
- Your partner pharmacy ships Usually within 1 to 2 business days, free
Key takeaways
- Switching takes a licensed provider’s prescription. Self-pay Zepbound costs $299 to $699 per 28 days (checked November 1, 2026).
- Compounded tirzepatide isn’t FDA-approved. A provider prescribes it only when it offers a significant difference for you.
- Bring milligrams, not units. Every Zepbound dose is 0.5 or 0.6 mL; a compounded vial’s units depend on its strength.
- Keep your weekly day. Your first compounded dose usually replaces your next Zepbound dose, as your provider directs.
- Insured or on Medicare? If you qualify for Lilly’s savings card or Medicare’s $50
GLP-1 Bridge, staying on Zepbound may cost less. - At NexLife, compounded tirzepatide is $139 a month on the 12-month plan, or $169 month to month, at every dose.
The NexLife Price Match Guarantee†
Paying less elsewhere?
Keep your price. Upgrade your care.
Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.
- 1Send a receipt from the last 60 days
- 2A NexLife provider reviews your prescription
- 3Pay your matched price, at every dose
Locked while your plan is activeSame price at every doseNo membership fee
†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.
Can you switch?
Can you switch from Zepbound to compounded tirzepatide?
Yes, if a licensed provider decides compounded tirzepatide is right for you. Compounded tirzepatide isn’t FDA-approved and isn’t a generic Zepbound. A provider prescribes it only when it offers a significant difference for you.
Switching may fit you if
- You pay for Zepbound yourself, and the price is hard to keep up.
- Your plan stopped covering Zepbound, or never covered it.
- Lilly’s savings card doesn’t bring your cost down far enough.
- You’re comfortable drawing a dose from a vial with a syringe.
Staying on Zepbound may make more sense if
- Your insurance covers Zepbound. With Lilly’s savings card, you may pay as little as $25 for up to a 3-month fill of single-dose pens; the card ends December 31, 2026.
- You have Medicare Part D and qualify for the
GLP-1 Bridge: the Zepbound KwikPen for no more than $50 a month, through December 31, 2027. - You want the FDA-approved medicine that was studied in Lilly’s trials.
- You’d rather keep a pen than draw doses from a vial.
“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”
New to compounded medicine? Start with compounded tirzepatide: its safety, rules and cost. Then compounded vs. brand-name tirzepatide: what’s different.
On Mounjaro instead? Mounjaro, like Zepbound, is a tirzepatide brand name; it’s approved for type 2 diabetes. A provider reviews your blood-sugar treatment before anything changes, so don’t stop it on your own. The questions below cover it.
Step by step
How do you switch from Zepbound to compounded tirzepatide?
In six steps, from your last Zepbound dose to your first compounded one. Your provider decides the dose; your new vial’s strength decides the units.
- Write down your Zepbound dose in milligrams. Add your last dose date and any side effects. A photo of your label helps.
- Begin your assessment before you run out. Keep taking Zepbound as prescribed until your provider confirms your next step.
- Let a licensed provider decide. They decide whether compounded tirzepatide is right for you, and at what dose. It’s a new prescription, and not 2.5 mg by default.
- Check your new vial’s label. Your units come from your dose and the vial’s strength in mg per mL, so your old Zepbound mark isn’t your new dose.
- Ask for a walk-through. Zepbound’s label asks for new training whenever your presentation changes. Ask for the same when you start a vial.
- Switch on your next weekly day. Your first compounded dose usually falls on the day your next Zepbound dose would be due, as your provider directs. Never take both.
The six steps above, in short. Your prescription, your vial’s label and your provider’s instructions come first.
Your dose
Why don’t your Zepbound units carry over?
Because every Zepbound dose comes in a set volume: 0.5 mL in a single-dose pen or vial, and 0.6 mL in a KwikPen or multi-dose vial, whatever the strength (label revised August 2026). A compounded vial has its own strength, so the same dose usually takes a different number of units.
What your Zepbound delivers per dose
| Your weekly dose | Single-dose pen or vial | KwikPen or multi-dose vial (4 doses) |
|---|---|---|
| 2.5 mg starting dose | 0.5 mL, at 5 mg per mL | 0.6 mL, at 4.17 mg per mL |
| 5 mg | 0.5 mL, at 10 mg per mL | 0.6 mL, at 8.33 mg per mL |
| 7.5 mg | 0.5 mL, at 15 mg per mL | 0.6 mL, at 12.5 mg per mL |
| 10 mg | 0.5 mL, at 20 mg per mL | 0.6 mL, at 16.7 mg per mL |
| 12.5 mg | 0.5 mL, at 25 mg per mL | 0.6 mL, at 20.8 mg per mL |
| 15 mg the maximum | 0.5 mL, at 30 mg per mL | 0.6 mL, at 25 mg per mL |
Swipe the table sideways to see every column.
From the Zepbound prescribing information, section 3 (revised August 2026), read November 1, 2026. The multi-dose strengths are the label’s; the single-dose ones are its milligrams divided by 0.5 mL. Every dose is taken once a week.
The volume stays put. The strength changes. If you drew Zepbound from vials, you measured 0.5 mL or 0.6 mL every week, whatever your dose: the 50 or 60 mark on a U-100 syringe. In a compounded vial, the mark depends on the vial’s strength and your dose.
Your old mark isn’t your new dose. At 2.5 mg, a Zepbound single-dose vial is 0.5 mL, the 50-unit mark. From a 20 mg/mL compounded vial, 50 units is 10 mg: four times that dose. Draw only what your new prescription and label say.
The same dose in a compounded vial (example only)
Example only: follow your label and your prescription. Your prescription and your vial’s label set your dose. If they don’t match this table, call or text us at
| Dose | 10 mg/mL vial | 12.5 mg/mL vial | 20 mg/mL vial |
|---|---|---|---|
| 2.5 mg | 25 units | 20 units | 12.5 units |
| 5 mg | 50 units | 40 units | 25 units |
| 7.5 mg | 75 units | 60 units | 37.5 units |
| 10 mg | 100 units, a full 1 mL syringe | 80 units | 50 units |
| 12.5 mg | Over 1 mL | 100 units, a full 1 mL syringe | 62.5 units |
| 15 mg | Over 1 mL | Over 1 mL | 75 units |
Swipe the table sideways to see every column.
Example only: follow your label and your prescription. Units on a U-100 insulin syringe (100 units = 1 mL): units = dose in mg ÷ vial strength in mg/mL × 100. “Over 1 mL” means that dose doesn’t fit a 1 mL syringe at that strength. Your vial may have another strength; the formula works for any.
Every dose and strength, worked out: our tirzepatide dosage chart has a converter for any vial.
Not sure of your units? Call or text
Will you restart at 2.5 mg?
Not by default. A licensed provider reviews the dose you take now, when you last took it and how you’re doing, then decides where you start. After a longer break, they may start you lower, to lower the risk of stomach side effects. On Zepbound’s label, 2.5 mg is the starting dose, not a maintenance dose.
Missed a few weeks? Here’s how a break changes things: restarting tirzepatide after a break.
New device, new training. Zepbound’s label asks providers to train you again whenever your Zepbound presentation changes, say from pen to vial. Ask for the same walk-through when you start a compounded vial. Here’s how to inject from a vial.
Timing
When do you take your first compounded dose after Zepbound?
Usually on the day your next Zepbound dose would be due, as your provider directs. Zepbound’s label sets the rules for a late dose and for moving your dose day.
| When | What to do |
|---|---|
| Before your last Zepbound dose | Start your assessment while you still have doses left. Keep taking Zepbound as prescribed until your provider confirms your next step. |
| Day 0 your last Zepbound dose | Take it as usual, on your regular day. |
| Day 7 your next weekly day | Usually the day of your first compounded dose, at the dose your provider prescribed. |
| Running late | Zepbound’s label: a dose up to 4 days (96 hours) late can still be taken. After that, skip it and take the next one on your regular day. |
| Moving your dose day | The label allows it, as long as doses are at least 3 days (72 hours) apart. |
| Don’t stack doses | One weekly dose, from one product. The label advises against using Zepbound with other tirzepatide products. |
Swipe the table sideways to see every column.
From the Zepbound prescribing information, sections 1 and 2.3 (revised August 2026), read November 1, 2026. Your provider’s instructions come first.
Why start early? A licensed provider reviews your history before anything is prescribed, and your medication has to reach you. Starting while you still have Zepbound left keeps your weekly day on track.
In their words
What does the Zepbound label say that matters when you switch to compounded tirzepatide?
Two lines from the label behind this page’s advice: why you don’t start over at 2.5 mg by default, and why you never take both.
Switching doesn’t mean starting over by default: your provider reviews the dose you take now, and the label is clear about what 2.5 mg is for:
“The 2.5 mg dosage is for treatment initiation and is not approved as a maintenance dosage.”
Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026
Why it’s one weekly dose, from one product, and never Zepbound and compounded tirzepatide on top of each other:
“ZEPBOUND contains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended.”
Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, section 1, revised August 2026
Day to day
What changes day to day after switching to a compounded vial?
Mostly the routine: a vial, a new syringe for every dose and a label you check each time. Questions about any of it come to us, 24/7.
Vial and syringe
You draw each dose from the vial with a new needle and syringe. Here’s how to inject from a vial, step by step.
Storage and dates
Store it as its label says. The FDA recommends discarding a multi-dose vial within 28 days after first use, even if some is left, and not using one that arrives warm. More on storing compounded tirzepatide.
Your label
It gives the strength in mg per mL, what’s in the vial and its beyond-use date. Check the strength on every new vial: a new strength changes your units.
Who you call
Us, 24/7, at
(949) 818-8000 , by call or text. Questions about your vial or your delivery come to us, not the pharmacy.
Side effects after the switch. Compounded tirzepatide wasn’t studied in Zepbound’s trials, so there’s no trial data on switching. On Zepbound’s label, most nausea, vomiting and diarrhea came while the dose was going up, and eased over time. Tell your provider about anything new or stronger. More on tirzepatide side effects.
Measuring matters. The FDA says it has received reports of side effects, some needing a hospital stay, that may be linked to dosing errors with compounded semaglutide. It encourages patients to ask their provider how to measure the intended dose. If a number on your label surprises you, ask before you inject.
Cost
What will you pay: Zepbound vs. compounded tirzepatide at NexLife?
Zepbound’s self-pay price rises with the dose: $299 to $699 per 28 days from Lilly, by dose and refill timing (checked November 1, 2026). Compounded tirzepatide at NexLife costs the same at every dose.
| Weekly dose | Zepbound, self-pay (per 28 days) | NexLife, 12-month plan (per month) | NexLife, month to month (per month) |
|---|---|---|---|
| 2.5 mg starting dose | $299 | $139 | $169 |
| 5 mg | $399 | $139 | $169 |
| 7.5 mg | $449 with a refill within 45 days; $499 without | $139 | $169 |
| 10 mg | $449 with a refill within 45 days; $699 without | $139 | $169 |
| 12.5 mg | $449 with a refill within 45 days; $699 without | $139 | $169 |
| 15 mg | $449 with a refill within 45 days; $699 without | $139 | $169 |
Swipe the table sideways to see every column.
Zepbound: Lilly’s self-pay prices for the KwikPen and single-dose vials at LillyDirect, medication only; Lilly’s month is 28 days (checked November 1, 2026). Lilly’s KwikPen self-pay card ends December 31, 2026, under its current terms. NexLife: compounded tirzepatide, per month, all in, the same at every dose. Compounded tirzepatide isn’t FDA-approved; Zepbound is. If insurance covers Zepbound for you, it may cost less.
Insured? If your plan covers Zepbound single-dose pens, Lilly’s savings card can bring a 1-, 2- or 3-month fill down to as little as $25, with up to $100 off a month. The card ends December 31, 2026. If that’s you, staying on Zepbound may cost less.
On Medicare? If you qualify for Medicare’s
The medicine, or the whole package? Lilly’s prices are for the medication. The telehealth options Lilly lists charge their own fees, from about $25 to $299 a visit, or $25 to $149 a month, not counting medication (checked November 1, 2026). NexLife’s price includes your provider, a nutrition plan, a coaching call and shipping.
Every Zepbound price, dated: Zepbound cost without insurance. Other options, priced: Zepbound alternatives.
See your price at every dose. Compounded tirzepatide at NexLife is $139 a month on the 12-month plan, or $169 month to month, all in. About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication
Check my eligibilityCompounded, not FDA-approved: a licensed provider prescribes it only when it offers a significant difference for you.At NexLife
Switching from Zepbound at NexLife, step by step
A licensed provider reviews your Zepbound dose before anything is prescribed. Here’s the path.
Tell us where you are
Your Zepbound dose in milligrams, your last dose date and any side effects. A photo of your label helps.
Your provider reviews the switch
They review your history and decide whether compounded tirzepatide is right for you, and at what dose. It’s a new prescription.
A partner pharmacy fills it
Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA) prepares it, with free expedited shipping.
Real people, 24/7
Questions about your dose, your vial or your delivery come to us at
(949) 818-8000 , call or text. A nutrition plan and a 1:1 coaching call are included.
About the Price Match Guarantee†. It covers compounded medication only: new members switching from another licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. Zepbound isn’t matched, whether it comes through insurance, LillyDirect or another program. See the terms.
Paying with HSA or FSA? Both work, and NexLife provides a letter of medical necessity. Affirm, Klarna and Afterpay are at checkout too.
Going back
Can you go back to Zepbound later?
Yes, with a Zepbound prescription from a prescriber who offers it; NexLife’s providers prescribe compounded medicines only. Your dose in milligrams is again the number that matters.
If coverage comes back
Lilly’s savings page says Zepbound coverage has been restored on select CVS Caremark formularies (read November 1, 2026). Ask your plan whether it covers Zepbound for you.
If you join Medicare Part D
Medicare’s
GLP-1 Bridge covers the Zepbound KwikPen for no more than $50 a month if you qualify, through December 31, 2027.The same care in reverse
Bring your dose in milligrams and your last dose date. Take your first Zepbound dose when your new prescriber says, and ask to be shown your new pen or vial: the label asks for that training.
What does NexLife cost?
One flat price at every dose.
No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†
GIP + 12-month plan $139/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan; $169/mo month to month.
Check my eligibilityCompounded, not FDA-approved · Not prescribed? No charge for medication
12-month plan $119/mo
Semaglutide
Weekly
Compounded, not FDA-approved · Not prescribed? No charge for medication
Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms
Switching from Zepbound: your questions
Fair questions about NexLife
- Will my price go up with my dose?
- No. You pay the same at every dose.
- What if I’m not prescribed?
- You aren’t charged for medication.
- Can I cancel?
- Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
- Do I need insurance?
- No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.
Can I switch from Zepbound to compounded tirzepatide?
You can switch from Zepbound to compounded tirzepatide if a licensed provider decides it’s right for you; bring your dose in milligrams, not units. Compounded tirzepatide isn’t FDA-approved and isn’t a generic Zepbound. If insurance covers Zepbound at a low copay, staying on it may cost less.
Will I have to start over at 2.5 mg?
Not by default. A licensed provider reviews the dose you take now, when you last took it and how you’re doing, then decides where you start. After a longer break, they may start you lower, to lower the risk of stomach side effects. Never pick your own starting dose.
How many units is my Zepbound dose in a compounded vial?
It depends on the vial’s strength. On a U-100 syringe, units = your dose in mg ÷ the vial’s mg per mL × 100. At 20 mg/mL, 5 mg is 25 units; at 10 mg/mL, it’s 50 units. Example only: follow your label and your prescription.
Can I use the same units I drew from my Zepbound vial?
No. A Zepbound single-dose pen or vial dose is 0.5 mL, and each KwikPen or multi-dose vial dose is 0.6 mL, whatever the strength. A compounded vial has its own strength, so the same dose usually takes a different number of units. Draw what your new prescription and label say.
When should I take my first compounded dose?
Usually on the day your next Zepbound dose would be due, as your provider directs. Zepbound’s label says a dose up to 4 days late can still be taken; after that, skip it and keep your regular day. Don’t take Zepbound and compounded tirzepatide on top of each other.
How much will I save by switching from Zepbound?
It depends on your dose. From 7.5 mg up, Lilly’s self-pay Zepbound is $449 per 28 days with a refill within 45 days, or $499 to $699 without (checked November 1, 2026). Compounded tirzepatide at NexLife is $139 a month on the 12-month plan, or $169 month to month, at every dose. They’re different products: only Zepbound is FDA-approved.
Does the Price Match Guarantee† apply if I’m coming from Zepbound?
No. It covers compounded medication only: new members switching from another licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide, with a receipt from the last 60 days. Zepbound isn’t matched, from any source. NexLife’s regular prices apply: $139 a month on the 12-month plan, or $169 month to month, at every dose.
Can I switch from Mounjaro to compounded tirzepatide?
Possibly. Mounjaro is tirzepatide approved for type 2 diabetes, so a provider reviews your blood-sugar plan first; don’t stop it on your own. Its label warns that using it with insulin or a sulfonylurea may raise the risk of low blood sugar. Like Zepbound’s, its doses are 0.5 mL or 0.6 mL, so units don’t carry over.
Will my side effects change after switching?
There’s no trial data: compounded tirzepatide wasn’t studied in Zepbound’s trials. On Zepbound’s label, most nausea, vomiting and diarrhea came while the dose was going up, and eased over time. Tell your provider about anything new or stronger; we answer 24/7 at
Is compounded tirzepatide as effective as Zepbound?
There’s no trial data to say. Compounded tirzepatide wasn’t studied in Zepbound’s trials, and the FDA doesn’t verify the safety, effectiveness or quality of compounded drugs before they’re marketed. A provider prescribes it only when it offers a significant difference for you.
How should I store compounded tirzepatide?
As its label says, and check its beyond-use date. The FDA recommends discarding a multi-dose vial within 28 days after first use, even if some is left, and not using one that arrives warm. Questions about your vial come to us, 24/7, at (949) 818-8000.
How long does switching from Zepbound take?
The online health questions take about 3 minutes; bring your Zepbound dose in milligrams and your last dose date. NexLife’s partner pharmacy usually ships within 1 to 2 business days. Start before you run out, and keep taking Zepbound as prescribed until your provider confirms your next step.
Important safety information
Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Read the full safety information
In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other
Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at
† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.
About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.
Who wrote and medically reviewed this page?
Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.
Labels read and prices checked November 1, 2026.
- How we checked. Dosing facts come from the prescribing information for Zepbound and Mounjaro (tirzepatide), both revised August 2026, read on November 1, 2026. Zepbound prices are Lilly’s own, from LillyDirect and Zepbound’s savings page, checked the same day; the Medicare Bridge terms come from CMS and Lilly. The compounded units table is arithmetic, shown as an example only. We don’t give a personal dosing plan or a conversion from Zepbound: your provider sets your dose.
- Every fact, sourced. Each price and rule links to the page it comes from.
- How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
- Corrections, fast. See something wrong or out of date? Email care@nexlife.us and we’ll fix it.
Paying less elsewhere? We match it.†
Bring your Zepbound dose. We’ll take it from there.
Share your dose in milligrams, and a licensed provider decides if compounded tirzepatide is right for you. $139 a month on the 12-month plan, or $169 month to month, at every dose.
4.8 out of 5 on Trustpilot · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified
Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.
- 1Tell us about you
Start online with your health history.
- 2A licensed provider decides
Online, following your state’s rules. You’re prescribed only if treatment is right for you.
- 3We ship it, then stay with you
Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.
Sources
- Zepbound (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
- Mounjaro (tirzepatide) prescribing information, Eli Lilly (revised August 2026). Read November 1, 2026.
- LillyDirect: Zepbound KwikPen, single-dose vial and pen prices. Checked November 1, 2026.
- Lilly: Zepbound savings and self-pay terms. Checked November 1, 2026.
- LillyDirect: telehealth options for obesity. Checked November 1, 2026.
- CMS: Medicare
GLP-1 Bridge. Read November 1, 2026. - FDA: Compounding and the FDA, questions and answers. Read November 1, 2026.
- FDA: concerns with unapproved
GLP-1 drugs used for weight loss (updated October 1, 2026). Read November 1, 2026. - NexLife: pricing, every plan. Checked November 1, 2026.
- NexLife: Price Match Guarantee† terms. Read November 1, 2026.
- Eli Lilly and Company, on Drugs@FDA. Zepbound (tirzepatide) prescribing information, revised February 2026 (FDA’s copy). Read November 2, 2026.
- U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024; read November 2, 2026.
- U.S. Food and Drug Administration. Understanding the Risks of Compounded Drugs. Content current as of June 22, 2026; read November 2, 2026.
- U.S. Food and Drug Administration. Human Drug Compounding Laws. Content current as of December 17, 2024; read November 2, 2026.
- Centers for Medicare & Medicaid Services, Medicare.gov. Weight loss drugs. Read November 2, 2026.
- U.S. Food and Drug Administration. MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Content current as of October 30, 2026; read November 2, 2026.